Back to Journals » Therapeutics and Clinical Risk Management » Volume 16
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,217 | Dovepress* | 11,483+ | 1,700 | 13,183 | |
PubMed Central* | 2,734 | 752 | 3,486 | ||
Totals | 14,217 | 2,452 | 16,669 | ||
*Since 22 May 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 1 | 0 | 0 | 2 | 3 |
View citations on PubMed Central and Google Scholar